Document Detail

O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
MedLine Citation:
PMID:  21107199     Owner:  NLM     Status:  In-Process    
BACKGROUND: O6-methylguanine methyltransferase (MGMT) promoter methylation in adult glioblastomas (glioblastoma multiforme) is considered a promising molecular alteration, predictive of better response to temozolomide therapy and longer overall survival.
OBJECTIVE: To look at the frequency of MGMT methylation in glial tumors of all grades and types, and correlate this alteration with loss of heterozygosity 1p/19q, TP53 gene mutations, epidermal growth factor receptor (EGFR) amplification, and isocitrate dehydrogenase 1 (IDH1) mutations.
METHODS: One hundred two gliomas of various grades and subtypes were assessed by methylation-specific polymerase chain reaction for MGMT promoter methylation status. The results were correlated with 1p/19q status, EGFR amplification, TP53, and IDH1 mutations.
RESULTS: There was an inverse correlation of MGMT promoter methylation frequency with tumor grade, observed in 79.4%, 70.8%, and 56.8% of grade II, grade III, and grade IV gliomas, respectively. The difference was statistically significant in grade II vs IV tumors (P=.036). The majority of cases with 1p/19q loss of heterozygosity also showed MGMT methylation, although the association was not significant. There was no significant correlation of MGMT status with IDH1 mutation. In astrocytic tumors, there was no correlation of MGMT methylation with TP53 mutation or EGFR amplification.
CONCLUSION: MGMT promoter methylation was observed in a considerable proportion of all grades and subtypes of gliomas, with no significant correlation with other known genetic alterations. On extensive literature review, in both low- and high-grade gliomas, wide variability of data on the frequency of MGMT methylation and its association with other molecular alterations from various centers was noted, mostly owing to technical causes. This raises questions regarding the capacity of this test for use as an objective and reproducible marker for customized treatment in individual cases.
Prerana Jha; Vaishali Suri; Ayushi Jain; Mehar Chand Sharma; Pankaj Pathak; Pankaj Jha; Arti Srivastava; Ashish Suri; Deepak Gupta; Kunzang Chosdol; Parthoprasad Chattopadhyay; Chitra Sarkar
Related Documents :
14722919 - Genetic characterization and structural analysis of vhl spanish families to define geno...
19671679 - Oncogenic activating mutations are associated with local copy gain.
12566309 - Genotypic and phenotypic characterization of a putative tumor susceptibility gene, gnmt...
10208879 - The mouse ortholog of the human smarcb1 gene encodes two splice forms.
18986479 - Absence of fumarate hydratase mutation in a family with cutaneous leiomyosarcoma and re...
21575609 - An abca1 truncation shows no dominant negative effect in a familial hypoalphalipoprotei...
7460369 - Sporadic occurrence of duchenne muscular dystrophy: evidence for new mutation.
3970589 - The genetic basis of porphyria cutanea tarda.
17931229 - Polymorphic microsatellite markers for genetic analysis of collagen genes in suspected ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neurosurgery     Volume:  67     ISSN:  1524-4040     ISO Abbreviation:  Neurosurgery     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7802914     Medline TA:  Neurosurgery     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1681-91     Citation Subset:  IM    
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Activation of nuclear factor ?B in cerebral arteriovenous malformations.
Next Document:  Critical influence of framing coil orientation on intra-aneurysmal and neck region hemodynamics in a...